Related Experiment Video
Updated: May 20, 2026
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Annual Inhaled Drug Delivery Conference
Andrea Leone-Bay1, Chad Smutney
1MannKind Corporation, 28903 North Avenue Paine, Valencia, CA 91355, USA aleone-bay@mannkindcorp.com
Therapeutic Delivery
|July 27, 2012
Summary
The 2010 Annual Inhaled Drug Delivery Conference explored pulmonary and systemic disease treatments using inhaled medicines. Experts discussed advancements for conditions like asthma, cystic fibrosis, and novel applications for systemic diseases.
Area of Science:
- Pharmacology and Therapeutics
- Drug Delivery Systems
- Respiratory Medicine
Background:
- The conference convened experts to discuss inhaled drug delivery advancements.
- Focus areas included traditional pulmonary indications and novel systemic disease applications.
- Key therapeutic areas covered were asthma, cystic fibrosis, and chronic obstructive pulmonary disease.
Discussion:
- Exploration of the inhalation route for treating systemic diseases such as irritable bowel disease, schizophrenia, migraine, diabetes, and obesity.
- Discussion on the challenges and opportunities in developing inhaled formulations for non-pulmonary targets.
- Emphasis on optimizing drug delivery and patient outcomes through innovative inhalation technologies.
Key Insights:
- Inhaled drug delivery offers a versatile platform beyond respiratory conditions.
- Novel applications are expanding the therapeutic potential of the inhalation route.
- Technological advancements are crucial for successful systemic drug delivery via inhalation.
Outlook:
- Continued research into inhaled therapies for a broader range of systemic diseases.
- Development of next-generation inhaler devices for improved efficacy and patient compliance.
- Potential for inhaled medications to offer alternative, non-invasive treatment options.
Related Concept Videos
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:18Additional Routes of Drug Administration
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.